View from the Board—Navigating New Funding Rounds with Current VC Directors

Bio Investor Forum 2017

10/17/2017 03:15 p.m. - 04:10 p.m.

Life Sciences and Emerging Companies + Venture Capital

Westin St. Francis Hotel
335 Powell Street
San Francisco, CA 94102

Michael J. O'Donnell

Michael J. O'Donnell

Speaking Engagement

When raising a seed round of venture capital, the focus of founders tends toward securing meetings and “acing” their pitches. It is a critical moment in the growth of an early-stage biotech that the first interested party is secured in order to more easily convince other investors to join and complete that round of funding. But what happens when you do succeed in generating interest and commitments for your initial round, and the focus shifts to fundraising new funding rounds? CEOs must then walk the fine line during discussions with the current board regarding new investor capital contributions, dilution rights, criteria for new board members, and the overall, long-term health of the company. The panel of start-up executives, directors, and investors will discuss their perspectives on how to crystalize and close subsequent-stage investment rounds, a complex and unclear path from the outside, but a vital step in the process for founders, while navigating the many personalities and interests involved.

Moderator: Michael J. O’Donnell, Partner, Morrison & Foerster LLP

Panelists:

  • Rajeev Dadoo, PhD, Partner, S.R. One
  • David H. Donabedian, PhD, Chief Executive Officer, Axial Biotherapeutics; Partner, Longwood Fund
  • Julie Papanek Grant, Partner, Canaan Partners
  • Julia C. Owens, PhD, President & CEO, Millendo Therapeutics, Inc.
  • Camille Samuels, Partner, Venrock

Email Disclaimer

Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

©1996-2017 Morrison & Foerster LLP. All rights reserved.